DE60328747D1 - Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen - Google Patents

Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen

Info

Publication number
DE60328747D1
DE60328747D1 DE60328747T DE60328747T DE60328747D1 DE 60328747 D1 DE60328747 D1 DE 60328747D1 DE 60328747 T DE60328747 T DE 60328747T DE 60328747 T DE60328747 T DE 60328747T DE 60328747 D1 DE60328747 D1 DE 60328747D1
Authority
DE
Germany
Prior art keywords
autoantibodies
purification
ivig
polyreactive autoantibodies
polyreactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60328747T
Other languages
English (en)
Inventor
Real Lemieux
Josee Lamoureux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hema Quebec
Original Assignee
Hema Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31495996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60328747(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hema Quebec filed Critical Hema Quebec
Application granted granted Critical
Publication of DE60328747D1 publication Critical patent/DE60328747D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyethers (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE60328747T 2002-08-20 2003-08-20 Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen Expired - Lifetime DE60328747D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40441602P 2002-08-20 2002-08-20

Publications (1)

Publication Number Publication Date
DE60328747D1 true DE60328747D1 (de) 2009-09-24

Family

ID=31495996

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60328747T Expired - Lifetime DE60328747D1 (de) 2002-08-20 2003-08-20 Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen

Country Status (4)

Country Link
US (1) US20040101909A1 (de)
EP (1) EP1394183B1 (de)
AT (1) ATE439381T1 (de)
DE (1) DE60328747D1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE518886T1 (de) * 2003-06-09 2011-08-15 Redox Reactive Reagents L L C Verfahren zur änderung der bindungsspezifität von plasmaproteinen durch oxidations- reduktionsreaktionen
EP1652859A1 (de) 2004-11-02 2006-05-03 ZLB Behring AG Immunoglobulinfraktionen
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
EP2233499A1 (de) * 2009-03-26 2010-09-29 CSL Behring AG Antikörperzusammensetzung mit veränderter Fab-Sialylierung
EP2258727A1 (de) * 2009-05-27 2010-12-08 Wezen Biopharmaceuticals S.r.l. A Socio Unico Immunglobulinzubereitung zur Behandlung einer Autoimmunerkrankung und Immunsystemstörungen
US20100330102A1 (en) * 2009-06-26 2010-12-30 Wezen Biopharmaceuticals Srl A Socio Unico Immunoglobulin preparation for the treatment of hiv-1 infection
EP2482074A1 (de) * 2011-01-27 2012-08-01 Medizinische Hochschule Hannover Verfahren und Mittel zur Diagnose von Vaskulitis
US9957319B2 (en) 2011-12-28 2018-05-01 Immunoqure Ag Method of isolating human antibodies
PT2961426T (pt) 2013-02-26 2019-12-09 Baxalta Inc Tratamento de transtornos do sistema nervoso central por administração intranasal de imunoglobulina g
CN113801297A (zh) 2016-04-15 2021-12-17 拜克门寇尔特公司 光敏大分子及其用途
CN109843327B (zh) 2016-07-07 2022-05-13 小利兰·斯坦福大学托管委员会 抗体佐剂缀合物
JP2020511501A (ja) 2016-12-13 2020-04-16 ボルト バイオセラピューティクス、インコーポレーテッド 抗体アジュバント複合体
US20210284750A1 (en) 2017-04-14 2021-09-16 Bolt Biotherapeutics, Inc. Immunoconjugate Synthesis Method
CN112153988A (zh) 2018-05-17 2020-12-29 博尔特生物治疗药物有限公司 免疫缀合物
CA3110510A1 (en) 2018-08-29 2020-03-05 Bolt Biotherapeutics, Inc. Immunoconjugates targeting egfr
BR102019025989A2 (pt) 2018-12-14 2020-06-23 Beckman Coulter, Inc. Modificação de corantes poliméricos e aplicações
US20220347312A1 (en) 2019-09-04 2022-11-03 Bolt Biotherapeutics, Inc. Immunoconjugate Synthesis Method
JP2023550721A (ja) 2020-11-13 2023-12-05 ベックマン コールター, インコーポレイテッド 蛍光性ポリマーコンジュゲートと生物学的試料中の細胞との間の非特異的相互作用を低下させるための添加剤
CA3207591A1 (en) 2021-02-05 2022-08-11 Beckman Coulter, Inc. Compositions and methods for preventing non-specific interactions between polymer dyes-antibody conjugates
WO2023056460A1 (en) 2021-09-30 2023-04-06 Beckman Coulter, Inc. Water-soluble tetrahydropyrene based fluorescent polymers
WO2024007016A2 (en) 2022-07-01 2024-01-04 Beckman Coulter, Inc. Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives
WO2024044327A1 (en) 2022-08-26 2024-02-29 Beckman Coulter, Inc. Dhnt monomers and polymer dyes with modified photophysical properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124719A (en) * 1979-03-22 1980-09-26 Kowa Co Preparation of immune globulin administrable by intravenous injection
DE19505266C1 (de) * 1995-02-16 1996-10-02 Brahms Diagnostica Gmbh Verwendung von polyklonalen humanen anti-hTg-Autoantikörpern als Reagenz für die klinische Diagnostik von Schilddrüsen-Autoimmunerkrankungen sowie Reagenziensatz für eine Bestimmung von anti-hTg-Autoantikörpern in Patientenseren
DE19900503A1 (de) * 1999-01-08 2000-07-13 Apotech Res & Dev Ltd Verwendung einer Zusammensetzung zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen mit erhöhten extrazellulären FasL-Titern, Verfahren zur prophylaktischen Eignungs- bzw. Qualitätskontrolle derselben, Verfahren zur Herstellung von Arzneimitteln zur Behandlung obiger Krankheiten mit gesteigerter Wirksamkeit
FR2794461B1 (fr) * 1999-06-07 2004-01-23 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice

Also Published As

Publication number Publication date
EP1394183A1 (de) 2004-03-03
ATE439381T1 (de) 2009-08-15
EP1394183B1 (de) 2009-08-12
US20040101909A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
DE60328747D1 (de) Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen
DE602004029252D1 (de) Aglycosyl-anti-cd154 (cd40-ligand) antikörper und deren verwendungen
ATE354655T1 (de) Humane antikörper gegen ctla-4 und deren verwendungen
EP1423510A4 (de) Antikörperglykosylierungsvarianten mit erhöhter antikörperabhängiger zellulärer zytotoxizität
ZA200508389B (en) Humanized antibodies to interferon alpha receptor-1(IFNAR-1)
ATE470676T1 (de) Anti-vegf-2 antikörper
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
BR0307788A (pt) método de redução e tratamento de imunossupressão induzida por uv-b
ES2148332T3 (es) Procedimiento para la produccion de concentrado de inmunoglobulinas g.
DE60236528D1 (de) Schwach gefärbte natriumarme benzoxazinon-uv-absorber und verfahren zu ihrer herstellung
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
HK1071898A1 (en) Recombinant antibodies, and compositions and methods for making and using the same
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
ATE264388T1 (de) Umgestaltete monoklonale antikörper gegen ein immunglobulinisotyp
DE60226253D1 (de) Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
ATE401912T1 (de) Methoden der zubereitung von immunglobulin und dessen verwendungen
BR0112123A (pt) Composto
ATE414154T1 (de) Moraxella (branhamella) catarrhalis antigene
ATE303390T1 (de) Sulfat von cephemverbindung
BR9611520A (pt) Composto hemo-reguladores.
DE69010897T2 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
ATE421586T1 (de) Moraxella (branhamella) catarrhalis antigene
FI20011469A (fi) Savukaasujen puhdistusprosessi
RU93035807A (ru) Способ лечения юношеского эпифизиолиса

Legal Events

Date Code Title Description
8363 Opposition against the patent